Dizziness on a GLP-1: Why Semaglutide and Tirzepatide Can Make You Lightheaded

You get out of bed, the room tilts, and for two or three seconds the edges of your vision go grey. Then it passes.

Plenty of people on semaglutide or tirzepatide describe exactly that moment, usually in the first few months or right after a dose increase. Dizziness is a listed side effect of both medicines, and in most cases the cause is mundane: less water and salt coming in, more fluid going out, and a blood pressure that is falling as weight comes off.

Mundane does not mean ignorable. A head rush on standing can end in a fall, and a small share of people on GLP-1 medicines develop blood pressure that is genuinely too low. This article covers how often dizziness shows up in the trials, the mechanisms behind it, who carries more risk, and which symptoms need a call to a prescriber.

How common is dizziness on semaglutide and tirzepatide?

Roughly double the placebo rate, but still a minority

Dizziness affects somewhere between 1 in 12 and 1 in 20 adults on full-dose GLP-1 treatment for weight loss. The Wegovy prescribing information reports dizziness in 8 percent of adults on semaglutide 2.4 mg in the pooled obesity trials, against 4 percent on placebo. The Zepbound prescribing information reports about 4 to 5 percent on the 10 mg and 15 mg doses, against 2 percent on placebo.

The placebo numbers are worth a second look. Between 2 and 4 percent of people on an inactive injection also reported dizziness, because lightheadedness is common in everyday life, especially among adults who are cutting calories. The extra risk attributable to the drug is therefore about 3 to 4 percentage points. That is real, and it is also far lower than the rates of nausea, which ran above 40 percent on semaglutide in STEP 1.

Why do GLP-1 medicines make some people dizzy?

Less fluid in, more fluid out, lower pressure overall

GLP-1 dizziness mostly comes from a smaller volume of blood in circulation meeting a lower baseline blood pressure. The brain sits above the heart, so every time a person stands, gravity pulls around 500 to 800 mL of blood down into the legs and abdomen. Healthy reflexes tighten blood vessels and nudge up heart rate within seconds. When circulating volume is low, those reflexes have less to work with, and the result is a brief drop in blood flow to the brain.

Several features of GLP-1 treatment push volume down at the same time. Appetite suppression cuts food intake, and food quietly supplies a meaningful share of daily water and most daily sodium. Many people also drink less, because a full-feeling stomach leaves little room for fluids. Vomiting and diarrhea, most common in the weeks after a dose increase, remove water and electrolytes directly.

Underneath all of that, weight loss lowers blood pressure. Lower insulin levels lead the kidneys to excrete more sodium, and less body fat means less strain on the circulation. For someone whose pressure started high, that is a welcome change. For someone whose pressure started normal or low, or who takes medication to bring it down, the same change can leave too little margin on standing.

What is orthostatic hypotension, and how is it different from ordinary dizziness?

A measurable pressure drop on standing

Orthostatic hypotension is a fall in blood pressure of at least 20 mmHg systolic or 10 mmHg diastolic within three minutes of standing. That definition comes from a 2011 consensus statement by Freeman and colleagues in Clinical Autonomic Research. The typical feeling is lightheadedness, dimmed or tunnel vision, or a sense of about to faint, starting seconds after getting up and easing when sitting or lying back down.

Ordinary dizziness is a broader word. Some people use it to mean spinning (vertigo), which usually points to the inner ear rather than blood pressure. Others mean unsteadiness or a vague fuzzy-headed feeling. The distinction matters, because a GLP-1 is a plausible cause of the lightheaded-on-standing pattern, while true spinning vertigo has a different list of causes and deserves its own evaluation. The Wegovy label groups hypotension, orthostatic hypotension, and decreased blood pressure together, and reports them in 1.3 percent of adults on semaglutide versus 0.4 percent on placebo.

How much do GLP-1 medicines lower blood pressure?

About 6 to 7 mmHg systolic on average

GLP-1 medicines lower systolic blood pressure by roughly 6 to 7 mmHg on average at full weight-loss doses. In STEP 1, systolic pressure fell by 6.2 mmHg on semaglutide 2.4 mg over 68 weeks, compared with 1.1 mmHg on placebo (Wilding, New England Journal of Medicine, 2021). In SURMOUNT-1, the pooled tirzepatide groups dropped 7.2 mmHg over 72 weeks, compared with 1.0 mmHg on placebo (Jastreboff, New England Journal of Medicine, 2022).

An average of 6 or 7 mmHg hides a wide spread. Some people see 15 or 20 mmHg falls, often those who lose the most weight or started with the highest readings. Part of the drop also appears within weeks, before much weight has been lost, which suggests GLP-1 medicines have some direct effect on blood vessels and sodium handling as well as the effect that comes from weight loss.

Who is most likely to get dizzy on a GLP-1?

People with less blood pressure margin to spare

People already taking blood pressure medicine carry the clearest extra risk of low blood pressure on a GLP-1. The Zepbound prescribing information reports hypotension in 2.2 percent of tirzepatide users on antihypertensive therapy, compared with 1.2 percent of users who were not. Diuretics such as hydrochlorothiazide or furosemide add a second route to fluid loss, and alpha blockers like doxazosin or tamsulosin are well known for causing lightheadedness on standing even without a GLP-1.

Other groups with less margin include older adults, whose blood pressure reflexes respond more slowly, people with diabetes-related nerve damage, and anyone with ongoing vomiting or diarrhea. Women with naturally low blood pressure often notice head rushes sooner than people who started with high readings. People who sharply restrict carbohydrate on top of a GLP-1 can also lose extra water early on, since stored glycogen holds water and is used up quickly.

Could the dizziness be low blood sugar instead?

Worth ruling out if you take insulin or a sulfonylurea

Low blood sugar is a possible cause of dizziness on a GLP-1, mainly for people who also take insulin or a sulfonylurea such as glipizide, glimepiride, or glyburide. GLP-1 medicines raise insulin release only when glucose is elevated, so on their own they rarely drive glucose dangerously low. Insulin and sulfonylureas do not have that safeguard, and the Wegovy and Zepbound labels both note that the doses of those medicines may need lowering.

Hypoglycemia tends to bring other signals alongside dizziness: shakiness, sweating, sudden hunger, a racing heart, or confusion. Blood pressure dizziness is usually tied to position and fades within seconds of sitting down. Anyone on glucose-lowering medicines who gets dizzy should check a glucose reading if a meter or continuous monitor is available, rather than guess.

What helps reduce lightheadedness on a GLP-1?

Small habits that protect blood volume

Reducing lightheadedness on a GLP-1 mostly means keeping fluid and salt intake from collapsing along with appetite, and giving blood pressure reflexes a few extra seconds. None of these steps has been tested as an intervention inside a GLP-1 trial. Each one addresses a mechanism with solid physiology behind it.

Could a lower dose GLP-1 protocol cause less dizziness?

Plausible, but untested

A lower dose GLP-1 protocol might cause less dizziness, though no study has measured it directly. The reasoning runs through the side effects that feed fluid loss. Nausea, vomiting, and diarrhea were all more frequent at higher doses and during escalation in the semaglutide and tirzepatide trials, and the Zepbound table shows dizziness concentrated in the 10 mg and 15 mg arms.

A smaller, steadier dose would also produce a slower fall in blood pressure, which gives prescribers more time to adjust any existing blood pressure medicines. The trade-off is that slower weight loss usually means a smaller long-term drop in pressure, which is one of the benefits many people want. Any change to dose should be made with a prescriber rather than alone.

When is dizziness on a GLP-1 a reason to get help?

Some patterns cannot wait

Dizziness on a GLP-1 needs urgent medical attention if it comes with fainting, chest pain, a pounding or irregular heartbeat, shortness of breath, or confusion. Dizziness with black or bloody stools, severe abdominal pain, or vomiting that prevents keeping fluids down also needs prompt care. Sudden weakness or numbness on one side, slurred speech, or loss of vision are signs of a possible stroke and call for emergency services.

Less dramatic dizziness still deserves a call to the prescriber if it happens most days, has caused a fall or near fall, or continues after the dose has been stable for several weeks. Very dark urine, passing little urine, or a dry mouth that will not settle are signs of dehydration, which on a GLP-1 can strain the kidneys. The Wegovy and Zepbound labels both warn about acute kidney injury linked to dehydration from gastrointestinal side effects.

Frequently Asked Questions